Alk-Abello Articles

US FDA accepts Merck & Co's BLA ragweed pollen allergy immunotherapy

9 May 2013

Merck & Co to initiate Ph III trial with HDM AIT (Mitizax) in North America

11 October 2012

Boehringer expands in China; Lundbeckfond ups ALK-Abello stake

15 December 2011

UK NICE negative on Sanofi’s Jevtana and GSK’s Benlysta but positive on ALK-Abello’s Pharmalgen

30 September 2011

ALK-Abello reveals progress with Mitizax in Japan and Europe

26 September 2011

Alk-Abello in up to 60 million-euro deal with Torii for allergy products in Japan

8 February 2011

Showing 1-6 of 6 articles

Go to beginningPrevious
  • 1
NextGo to end